You are here

  • Home
  • Archive
  • Volume 88, Issue 10
  • Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Citation Tools

Article menu

Download PDFPDF

Neuromuscular
Research paper
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kuwabara S, Mori M, Misawa S on behalf of the Glovenin-I CIDP Study Group, et al
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial
Journal of Neurology, Neurosurgery & Psychiatry 2017;88:832-838.